ResMed Surges And Retakes A Key Line As The Battle With Weight-Loss Drugs Rages
Investor's Business DailyResMed reported a strong December-quarter beat, an analyst said Thursday as RMD stock surged, retaking its 200-day moving average.
The post ResMed Surges And Retakes A Key Line As The Battle With Weight-Loss Drugs Rages appeared first on Investor'…